These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 37681080)
1. Prevalence of human papillomavirus infection in abnormal pap smears. Mishra J; Kalantri S; Raphael V; Dey B; Khonglah Y; Das A Cytojournal; 2023; 20():21. PubMed ID: 37681080 [TBL] [Abstract][Full Text] [Related]
2. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920 [TBL] [Abstract][Full Text] [Related]
3. Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear. Gothwal M; Nalwa A; Singh P; Yadav G; Bhati M; Samriya N J Obstet Gynaecol India; 2021 Feb; 71(1):72-77. PubMed ID: 33814802 [TBL] [Abstract][Full Text] [Related]
5. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions. Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728 [TBL] [Abstract][Full Text] [Related]
6. Improved abnormal Pap smear triage using cervical cancer biomarkers. Killeen JL; Dye T; Grace C; Hiraoka M J Low Genit Tract Dis; 2014 Jan; 18(1):1-7. PubMed ID: 23760145 [TBL] [Abstract][Full Text] [Related]
7. The prevelance of human papillomavirus (HPV) genotypes detected by PCR in women with normal and abnormal cervico-vaginal cytology. Beyazit F; Sılan F; Gencer M; Aydin B; Paksoy B; Unsal MA; Ozdemir O Ginekol Pol; 2018; 89(2):62-67. PubMed ID: 29512809 [TBL] [Abstract][Full Text] [Related]
8. Comparison of human papillomavirus DNA prevalence in atypical squamous cells of undetermined significance subcategories as defined by the original Bethesda 1991 and the new Bethesda 2001 Systems. Pirog EC; Erroll M; Harigopal M; Centeno BA Arch Pathol Lab Med; 2004 May; 128(5):527-32. PubMed ID: 15086283 [TBL] [Abstract][Full Text] [Related]
9. P16/Ki-67 Dual Staining in Positive Human Papillomavirus DNA Testing for Predictive Diagnosis of Abnormal Cervical Lesions in Northeastern Thai Women. Aromseree S; Wongjumpa W; Ekalaksananan T; Temtanakitpaisan A; Kleebkaow P; Srisathaporn S; Tongchai P; Pientong C Asian Pac J Cancer Prev; 2022 Oct; 23(10):3405-3411. PubMed ID: 36308365 [TBL] [Abstract][Full Text] [Related]
10. Atypical squamous cells of undetermined significance in liquid-based cytologic specimens: results of reflex human papillomavirus testing and histologic follow-up in routine practice with comparison of interpretive and probabilistic reporting methods. Levi AW; Kelly DP; Rosenthal DL; Ronnett BM Cancer; 2003 Aug; 99(4):191-7. PubMed ID: 12925979 [TBL] [Abstract][Full Text] [Related]
11. Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing? Liman AK; Giampoli EJ; Bonfiglio TA Cancer; 2005 Dec; 105(6):457-60. PubMed ID: 16104044 [TBL] [Abstract][Full Text] [Related]
12. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study. Dane C; Batmaz G; Dane B; Cetin A Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953 [TBL] [Abstract][Full Text] [Related]
13. The utility of high-risk HPV testing in the management of women 30 to 64 years of age with low-grade squamous intraepithelial lesions on cervical cytology. Selvaggi SM J Am Soc Cytopathol; 2015; 4(5):290-293. PubMed ID: 31051767 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar. Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783 [TBL] [Abstract][Full Text] [Related]
15. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Nieh S; Chen SF; Chu TY; Lai HC; Lin YS; Fu E; Gau CH Gynecol Oncol; 2005 Apr; 97(1):35-40. PubMed ID: 15790434 [TBL] [Abstract][Full Text] [Related]
16. [Detection of human papillomavirus L1 capsid protein expression in liquid-based cytology samples with abnormal cytology.]. Xiao W; Bian ML; Ma L; Liu J; Chen Y Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):887-91. PubMed ID: 20193413 [TBL] [Abstract][Full Text] [Related]
17. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute. Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733 [TBL] [Abstract][Full Text] [Related]
18. [HPV E6 and E7 mRNA combined with HPV 16 and 18 or 45 genotyping testing as a means of cervical cancer opportunistic screening]. Wang JJ; Dong J; Deng ZX; Wang PF; Zhang XX; Du Y Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):301-306. PubMed ID: 31154710 [No Abstract] [Full Text] [Related]
19. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H]. Wu Y; Zhao J; Hu J; Wu XW; Zhu LR Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267 [No Abstract] [Full Text] [Related]
20. Utility of P16 expression and Ki-67 proliferation index in ASCUS and ASC-H pap tests. Toll AD; Kelly D; Maleki Z Diagn Cytopathol; 2014 Jul; 42(7):576-81. PubMed ID: 24288264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]